Epidemiology and Clinical Characteristics of Emerging and Re-emerging Infectious Diseases With Epidemic Potential in Mali

University Clinical Research Center, Mali400 enrolled

Overview

This is a prospective observational study to include participants with a spectrum of emerging or unknown pathogens with the objective to determine etiology and clinical characteristics of those diseases.

Infectious diseases remain one of the leading causes of death worldwide despite innovations in medical research and the availability of new treatments. Emerging diseases include outbreaks of previously unknown diseases or known diseases where the incidence in humans has significantly increased in the past two decades. Detailed studies on emerging and re-emerging infectious agents to better understand pathogens' biology and host pathogenesis are mostly lacking. This study protocol is to prepare for a rapid coordinated clinical investigation of acute infections of emerging and re-emerging infectious agents in Mali. In collaboration with the Mali Ministry of Health and Public Hygiene, we will conduct an observational study to include participants with a spectrum of emerging or unknown pathogens with the objective to determine etiology and clinical characteristics of those diseases. Patients with suspected emerging or re-emerging infectious diseases within 15 km of Point G Hospital in Bamako will be invited to participate in this study.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Febrile Illness

Interventions

Observational StudyOTHER

observational study to include participants with a spectrum of emerging or unknown pathogens with the objective to determine etiology and clinical characteristics of those diseases

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Participants referred or managed by the National Disease Surveillance Committee, primary healthcare facilities, level-3 hospitals, or other facilities Adults and children of any age Unexplained fever (temperature greater than or equal to 38°C), recorded or reported, within 24 to 48 hours, regardless duration with at least one of the following signs or symptoms: * Unexplained bleeding * One or more generic symptoms (headache, tiredness, myalgia, arthralgia, diarrhea, anorexia, weight loss, rash) * Jaundice * One or more respiratory symptoms (cough, dyspnea, pharyngitis, rhinorrhea) * Guillain-Barré syndrome * Newborns with microcephaly or other brain defects * Agree to have samples collected and stored for further studies Exclusion criteria \- Participants may be excluded from enrolling in the study if they have any known medical disorders or other circumstances which, in the opinion of the investigator, might make participation unsafe or difficult (e.g. inability to obtain necessary samples, mental illness).

Locations (1)

University Clinical Research Center (UCRC) / USTTB

Bamako, Mali

RECRUITING

Outcomes

Primary Outcomes

Identify the etiologies and immediate outcomes of emerging and re-emerging diseases in Mali.

To identify the etiologies (e.g. lassa fever, measles, covid-19, zika, Ebola virus disease) of unexplained febrile illnesses in adults and children in Mali measured by the proportion of cases identified who are children, or who are adults.

Time frame: In 3 years

Central Contacts

Sounkalo DAO, MD

CONTACT

+223 72 27 49 71 sounkalod@icermali.org

Oumar GUINDO, PharmD, MPH

CONTACT

+22376410338 oumarmguindo@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.